Enzyme Drives Treatment Resistance in Ovarian Cancer - News Center
Researchers at Northwestern Medicine identify PRMT5 as a key driver in chemotherapy resistance for advanced ovarian cancer, revealing potential targets for treatment.
Understanding How Cancer Cells Adapt to Evade Treatment - News Center
The study reveals that ovarian cancer stem cells possess increased chromatin packing domains, enhancing their ability to adapt gene expression in response to chemotherapy.
This ancient resin holds promise for slowing cancer growth
Frankincense, derived from Boswellia trees, has shown promise in fighting ovarian cancer cells through a compound called AKBA, offering a gentler alternative to traditional treatments.